In contrast, patients without NAFLD and with BT only had significantly elevated TNF-α, IL-17, and IL-23 compared to those without BT (p < 0.001) (Fig. 3). This evidence concerns the gene IL17A and metabolic dysfunction-associated steatotic liver disease.